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1078–5The renewed strategy towards performing carotid endarterectomy (CEA) within 1e2 weeks of a patient presenting with
a TIA or minor stroke is based on a large body of evidence showing that the highest risk period for the patient is the first
seven days after the index event. Unfortunately, most stroke/vascular services are inadequately resourced to achieve this
target and many are more likely to be pre-occupied with treating large numbers of asymptomatic individuals. This paper
reviews the evidence underlying the current drive towards expedited intervention in patients presenting with TIA and
minor stroke. It will also try to provide reassurance to the surgeon as to how such a strategy can be reconciled with
understandable concerns that early CEA in symptomatic patients is associated with poorer perioperative outcomes.
 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Keywords: Stroke; Carotid; Endarterectomy; Angioplasty.4Introduction
‘‘Carotid intervention for recently symptomatic, severe
carotid stenosis should be regarded as an emergency pro-
cedure in patients who are neurologically stable, and
should ideally be performed within 48 hours of a tran-
sient ischaemic attack or minor stroke.’’
The National Stroke Strategy.1
The UK Department of Health, 5th December 2007.
The American Academy of Neurology (AAN) and the
American Heart Association (AHA) recommend that
carotid endarterectomy (CEA) be performed within
two weeks in patients presenting with a transient
ischaemic attack (TIA) or a non-disabling stroke.2,3
The available evidence, however, suggests that very
few centres achieve this threshold.4 In a 2006 survey
of practice in eleven centres in Holland, only 24% of
patients presenting with a TIA/minor stroke and
a 70e99% stenosis underwent endarterectomy within
6 months.5 In the recently completed GALA trial, thesponding author. Professor A. R. Naylor, Dept of Vascular
y, Clinical Sciences Building, PO Box 65, Leicester Royal Infir-
Leicester LE2 7LX, UK.
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884/000383 + 09 $34.00/0  2008 European Society for Vasculamedian delay to surgery was 80 days. In 1997, an
audit of UK practice found that the median delay
from index event to surgery was 189 days,6 falling to
45 days when repeated in 2007.7 While the latter exam-
ple represents a considerable improvement in practice,
it is nowhere near the AAN and AHA ‘two week’ rec-
ommendation and ‘light years’ from achieving the ‘48
hour’ aspiration of the United Kingdom Government.
So, why is there such a discrepancy between na-
tional/international recommendations and ‘real world’
practice? The answer is multifactorial but requires gov-
ernments and health providers to consider cerebral
vascular disease on a par (in terms of political and
fiscal priority) with cancer and heart disease. More
controversially, it requires surgeons/interventionists
to recognise that the current pre-occupation with treat-
ing vast numbers of asymptomatic patients will do little
to reduce the overall burden of stroke. It is an uncom-
fortable fact that even if one could identify every patient
with an asymptomatic 60e99% stenosis and perform
CEA/CAS with a 2.3% procedural risk, 97% of strokes
destined to occur in the community will still happen.4,8
This paper reviews the evidence underlying the
current drive towards expedited intervention in pa-
tients presenting with TIA and minor stroke. It will
also try to provide reassurance to the surgeon as to
how such a strategy can also be reconciled with
a recent report9 suggesting that ‘‘early CEA inr Surgery. Published by Elsevier Ltd. All rights reserved.
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operative outcomes.’’Level I, Grade a Evidence.
Most interventionists and surgeons cite data from the
international, randomised trials as being the level I,
Grade A evidence base upon which their clinical prac-
tice is founded (Table 1). In effect, ECST, VA and NAS-
CET showed that ‘recently symptomatic’ patients
(defined as events occurring within the preceding
6 months) with 50e99% NASCET stenoses benefited
from ‘intervention’, whilst ACAS and ACST found
that surgery was of significant benefit in asymptom-
atic patients with 60e99% stenoses.10e14 Armed with
such high quality data from more than 10,000 rando-
mised patients, the only remaining issue is usually
whether that ‘intervention’ should still be surgery or
carotid angioplasty with stenting (CAS).
Not surprisingly, attempts to divert contemporary
debate away from whether CEA or CAS is preferable
and back towards identifying who benefits most from
intervention is not always welcomed. For many, the
rationale is simple. If, for whatever, reason, CEA/
CAS cannot be performed within six months of the
index event, then surely the results from ACAS and
ACST justify any intervention thereafter? Why make
it any more complicated?
At first sight, this interpretation of the trials seems
logical, reasonable and difficult to counter. However,
anyone who does read beyond the ‘headlines’ will
realise that this is far too simplistic an interpretation.
It is an uncomfortable fact that the system currently
allows most practitioners of CEA and CAS to treatTable 1. Principle outcomes from the randomised trials
(a) Carotid Endarterectomy Trialists Collaboration*: Five year risk of ‘a
NASCET trials10e12
Trial Stenosis n 30-day CEA risk Five Year Risk
Surgery M
CETC <30% 1746 18.36% 15
CETC 30e49% 1429 6.7% 22.80% 25
CETC 50e69% 1549 8.4% 20.00% 27
CETC 70e99% 1095 6.2% 17.13% 32
CETC String 262 5.4% 22.40% 22
(b) ACST & ACAS13,14: Five year outcomes (including 30-day death/s
Trial Endpoint 30-day CEA risk Five Year Ri
Surgery
ACAS ipsilateral stroke 2.3% 11.0%
ACST ‘any stroke’ 2.8% 11.8%
n/b¼ no benefit conferred by CEA, ARR¼Absolute Risk Reducti
CEAs¼ number of strokes prevented at five years by performing 1000
* data derived from the CETC10e12 with all pre-randomisation angio
Eur J Vasc Endovasc Surg Vol 35, April 2008myriads of relatively ‘low risk for stroke’ patients
within nationally accepted guidelines, while the really
‘high risk’ patients suffer strokes with little chance of
undergoing any intervention. Just look again at Table 1
to see just how few strokes are prevented at five years
by operating on 1000 patients with symptomatic 50e
69% or 60e99% asymptomatic stenoses.
To this observer, the ongoing debate should not just
be about whether ACAS/ACST justifies intervention
should the 6 month ‘symptomatic’ threshold elapse
(they probably do), nor whether CEA or CAS is
‘king’ (just do the randomised trials properly), but
can health providers, physicians, surgeons and inter-
ventionists change attitudes and practice and then
prioritise resources towards those who really need
our help. Contrary to political and professional pref-
erences, this does not mean expending resources on
asymptomatic carotid screening programmes as the
number one priority. As will be shown, this money
would be far better being used to expedite the inves-
tigation and treatment of symptomatic patients within
one/two weeks of presentation. Once that has been
achieved, it is then reasonable to treat as many
asymptomatic patients as you like!Something Old.
In common with many of you, I was taught that; (i)
CEA should be delayed for 6e8 weeks after a stroke
because of the increased risk of haemorrhagic trans-
formation of the infarct, i.e. emergency surgery was
dangerous, (ii) early/expedited surgery (in general)
was probably associated with an increased rate of
complications, so why expose yourself to unnecessaryny stroke’ (including 30-day stroke/death) from the VA, ECST and
ARR RRR NNT Strokes prevented
per 1000 CEAsedical
.71% 2.6% n/b n/b none at 5 years
.45% þ2.6% 10% 38 26 at 5 years
.77% þ7.8% 28% 13 78 at 5 years
.71% þ15.6% 48% 6 156 at 5 years
.30% 0.1% n/b n/b none at 5 years
troke)
sk ARR RRR NNT Strokes prevented
per 1000 CEAsMedical
5.1% þ5.9% 54% 17 59 at 5 years
6.4% þ5.4% 46% 19 53 at 5 years
on, RRR¼Relative Risk Reduction, strokes prevented per 1000
CEAs at the risk quoted.
grams remeasured using NASCET method.
385Delay Comes With a Pricemedico-legal risk, especially as (iii), the risk of suffer-
ing a stroke in the first few weeks after presentation
was probably not really that high and (iv) early symp-
tom resolution was generally taken to be a sign that
urgent investigation/treatment was unnecessary.15
Interpretation: A little bit of delay in the system prob-
ably does no real harm and might, actually, be bene-
ficial to the patient (and possibly to the surgeon
regarding published risks). Outcome: No professional
impetus to change the way the system works.
This nihilistic attitude persists into the modern era,
is rarely mentioned in debates about developing the
roles of CEA and CAS and was completely ignored
in a recent survey of doctor’s attitudes towards ‘‘treat-
ing stroke as a medical emergency’’. In this study,
Wang16 ascertained that there was; (i) room for im-
provement in recognising symptoms due to stroke/
TIA (that in itself is a damning indictment of attitude
and practice), (ii) scepticism regarding the role of CEA
in asymptomatic individuals, which varied according
to the doctor’s specialty (no surprise there then) and
(iii) 28% of physicians would not administer tissue
plasminogen activator in acute stroke (but at least
the majority knew it was beneficial if administered
quickly). However not one single question was
directed towards ascertaining whether doctors knew
that rapid access to surgery was highly beneficial to
the very recently symptomatic patient.0 30
Days
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Fig. 1. Cumulative risk of stroke after transient ischaemic
attack (TIA) or minor stroke. Reproduced with permission
from Coull and the British Medical Journal.23Something New.
The recent drive towards promoting expedited inves-
tigation and intervention has not generally been led
by surgeons (with a few notable exceptions)17,18 but
rather by Neurologists and Stroke Physicians. In a se-
ries of surprisingly ‘basic’ methodological studies and
provocative editorials, they have challenged accepted
dogma and thrown down a very large gauntlet for
their surgical colleagues to respond to.19e31
The first myth to be challenged by the Neurologists
was the conventional teaching that the early risk of
stroke after TIA/minor stroke was only about 1e2%
at 7 days and 2e4% at 30 days. These data were
primarily derived from a collection of ‘cohort’ stu-
dies,19,22e24 which had largely stood the test of time
and which generally reassured surgeons that there
was no real need to change existing practice and inter-
vene urgently. However, these cohort studies tended to
recruit their patients some time after the index event,
patients suffering a stroke in the intervening period
were excluded, as were those who suffered a stroke
on the same day as their TIA. More importantly,
most patients were recruited following attendance atthe outpatient clinic or accident and emergency de-
partment and few were derived from prospective
community/population based environments.19,22e24
In short, these cohort studies were heavily biased in
their design and they influenced practice in a manner
more than was justified.
In a systematic review of 18 independent cohort
studies which reported the early risk of stroke in
10,216 patients presenting with a TIA, Giles observed
that the pooled risk of stroke was 5.2% at seven days,
i.e. about three to four times greater than is tradition-
ally quoted.31 However, this study encountered some
of the limitations alluded to earlier (e.g. many of the
constituent trials recruited from outpatient clinics or
the accident and emergency department etc). A sepa-
rate meta-analysis of three population based studies
(which used ‘face to face follow-up’) observed that
the risk of stroke at 2 days was 6.7% and was 10.4%
at seven days.31 Population based studies are more
likely to represent ‘real world’ practice and these fig-
ures suggest that the highest risk period for the TIA
patient is the first seven days after the index event.
How many medical and surgical units are ‘geared
up’ to deal with TIA/minor stroke patients this
quickly?
One of the three population based studies23 was
particularly informative as it also reported early
stroke risks for patients presenting with a minor
stroke as well as TIA (Fig. 1). Note that there was no
significant difference in the early risk of recurrent
stroke at 7, 30 and 90 days relative to mode of presen-
tation. ‘Conventional teaching’, however, dictates that
patients suffering a minor stroke should wait 6e8
weeks for CEA. As was actually observed in Coull’s
study, by that time, most of those destined to suffer
a stroke will have already done so.23 The surgeon is,Eur J Vasc Endovasc Surg Vol 35, April 2008
Table 3. ABCD criteria for predicting very early stroke risk*
Score
A Age 60 years 1
Age <60 years 0
B BP: systolic 140 mmHg or diastolic 90 mmHg 1
BP: neither of the above 0
C Clinical features: Unilateral weakness 2
Speech disturbance, no weakness 1
Other 0
D Duration of symptoms 60 minutes 2
10e59 minutes 1
<10 minutes 0
Maximum Score 6
* details derived from Rothwell.27
386 A. R. Naylorin effect, left with a ‘safer’ cohort of patients whose
long term risk of stroke is probably much less.
In an alternative approach to evaluating ‘early
stroke risk’, Rothwell combined four independent
patient databases comprising 2416 patients who had
presented with an ischaemic stroke.26 Approximately
one quarter of these stroke victims (549 patients)
reported a preceding TIA. Almost one fifth (17%) of
the preceding TIAs occurred on the same day as the
stroke, 9% happened on the day prior to the stroke,
while 43% of TIAs (overall) occurred within the seven
days prior to stroke onset.
Of course, not all strokes are secondary to thrombo-
embolic disease from the carotid artery and this could
confound meaningful interpretation of the data. Ap-
proximately 25% of strokes are due to small vessel
intracranial disease, while 15% are cardioembolic. In
order to correct for the effect of the underlying aetiol-
ogy on the risk of recurrent stroke, Lovett et al.
performed a meta-analysis of four studies which strat-
ified for underlying aetiology.24 Table 2 summarises
the principle findings. Early recurrent stroke was
extremely rare after small vessel (lacunar) stroke.
However, stroke due to ‘large artery’ disease (i.e pre-
dominantly involving the carotid artery) was associ-
ated with the highest rate of early recurrent stroke
(4% at 7 days, 12.6% at 30 days and 19.2% at 3 months).
The studies detailed so far clearly suggest that the
early risk of stroke after TIA/minor stroke is much
greater than previously thought and most centres
will logistically be unable to immediately change
practice in order to investigate and treat these patients
more quickly. It would, therefore, be helpful (in the
interim) if ‘higher risk’ subgroups of patients could
be identified for ‘fast-tracking’. A number of studies
have tried to identify clinical/imaging parameters
that are predictive of an increased risk of early recur-
rent stroke. These include presentation with; (i) motor
deficit,19,32 (ii) dysphasia or dysarthria,19,32 (iii) con-
tralateral occlusion, (iv) exhausted cerebral vascular
reserve,21 (v) age >60 years19 and (vi) diabetes melli-
tus.19 This theme was developed further by Rothwell
in the form of the ‘ABCD’ scoring system (Table 3),Table 2. Cumulative recurrent stroke risk stratified for underlying
aetiology*
7 days 1 month 3 months
‘large vessel
disease’
4.0%
(95%CI 0.2e7.8)
12.6%
(95%CI 5.9e19.3)
19.2%
(95%CI 11.2e27.2)
cardioembolic 2.5%
(95%CI 0.1e4.9)
4.6%
(95%CI 1.3e7.9)
11.9%
(95%CI 6.4e17.4)
‘small vessel
disease’
0.0% 2.0%
(95%CI 0.0e4.2)
3.4%
(95%CI 0.5e6.3)
* data derived from meta-analysis by Lovett.24
Eur J Vasc Endovasc Surg Vol 35, April 2008superseded by the ABCD2 version.27,33 The origins
and validation of this predictive scoring system has
been discussed in greater detail in the March Carotid
Masterclass.34 In summary, TIA patients with an
ABCD score of 0e3 incurred a 0% seven day risk of
stroke, increasing to 2.2% for a score of 4, 16.3% for
a score of 5 and 35% for patients with a maximum
score of 6.27 In the future, such scoring systems could
become invaluable in identifying patients meriting
emergency admission after suffering their TIA/minor
stroke (eg those with an ABCD score of 5þ).Something Borrowed.
Table 1 summarises the principle findings from the
randomised trials that have influenced practice most
of all. It will be noted that no attempt has been
made to separate NASCET, ECST and VA outcomes
in the symptomatic cohort of patients. This is because
the Carotid Endarterectomy Trialists Collaboration
(CETC) provided an invaluable service by combining
all of these data together, having remeasured all of the
pre-randomisation angiograms using the NASCET
measurement method.10e12 This database of >6000
patients is now the largest and most comprehensive
set of outcome data in symptomatic patients with
carotid disease (despite being somewhat historical).
More importantly, it’s very large size has enabled
a number of important subgroup analyses to be per-
formed that would go on to challenge many precon-
ceived notions about what really constitutes being
‘recently symptomatic’.
Table 4 details some of the CETC findings in a for-
mat slightly different to that used in Table 1. The
absolute risk reduction conferred by surgery (ARR),
the number needed to treat to prevent one stroke at
5 years (NNT) and the number of strokes prevented
per 1000 CEAs at 5 years (CVA/1000) are detailed for
three NASCET stenosis subgroups (50e69%, 70e99%
Table 4. Absolute risk reduction conferred by CEA in the 5 year cumulative risk of ipsilateral carotid territory ischaemic stroke (including
the peri-operative risk) in patients with a NASCET 50e99% stenosis, stratified for delay from index event to randomisation*
Time since
randomisation
50e69% stenoses 70e99% stenoses ALL 50e99% stenoses
ARR NNT CVA/1000 ARR NNT CVA/1000 ARR NNT CVA/1000
< 2 weeks 14.8 7 148 23.0 4 230 18.5 5 185
2e4 weeks 3.3 30 33 15.9 6 159 9.8 10 98
4e12 weeks 4.0 25 40 7.9 13 79 5.5 18 55
>12 weeks 2.9 nil nil 7.4 14 74 0.8 125 8
nil¼ no benefit conferred by CEA, ARR¼Absolute Risk Reduction (%) conferred by surgery over best medical therapy, NNT¼ number of
CEAs needed to be performed to prevent one stroke at 5 years, CVA/1000¼ number of strokes prevented at five years by performing 1000
CEAs.
* data derived from the CETC10e12 with all pre-randomisation angiograms remeasured using NASCET method.
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Fig. 2. Number of strokes prevented at 5 years by perform-
ing 1000 CEAs. Effect of gender and timing from event to
CEA on prevention of late stroke relative to degree of steno-
sis (recalculated from CETC data10e12 and reproduced with per-
mission from AR Naylor).4
387Delay Comes With a Priceand 50e99%) and stratified according to the delay be-
tween onset of symptoms and randomisation. In the
trials, CEA was performed (on average) within 7
days of randomisation (P Rothwell, personal communi-
cation). As can clearly be seen, the benefit conferred
by CEA was maximum if the delay between symptom
onset and randomisation was <2 weeks. In symptom-
atic patients with 50e69% stenoses, the ARR con-
ferred by surgery fell rapidly with time with no
benefit being apparent after 12 weeks had elapsed
(how many of you even consider this fact when dis-
cussing the rationales of surgery with some of your
patients?).
In symptomatic patients with 70e99% stenoses, the
benefit conferred by surgery again diminishes with
increasing delays to surgery (< 2 weeks, ARR¼ 23%
versus> 12 weeks, ARR¼ 7.4%), although the cumula-
tive benefit was greater than that observed in similar
time delayed patients with 50e69% stenoses. One im-
portant caveat to be borne in mind, however, is that
the ‘70e99%’ and ‘50e99%’ outcome data in Table 4
does include patients with angiographic evidence of
‘near occlusion’. The CETC have shown that CEA
does not confer significant benefit in patients with
this pattern of disease.10 If these patients are excluded,
the ARR conferred by CEA at 5 years increases to
30.2% for patients randomised< 2weeks with 70e
99% stenoses and to 17.6% (2e4 weeks), 11.4% (4e12
weeks) and 8.9% (>12 weeks).
These data were some of the first to really challenge
surgeons to question how their own practice influ-
enced long term patient benefit. Put quite simply,
surgeons who performed CEA very rapidly prevented
far more strokes than those whose practice allowed
excessive delays to occur. But there was more.
One further very important issue emerged from the
CETC secondary analyses; gender.12 Interestingly, not
one national guideline includes any recommendation
that gender might be an issue when discussing the ra-
tionales of intervention with symptomatic patients.
Fig. 2 details the number of strokes prevented at fiveyears by performing 1000 CEAs in patients with 50e
69% and 70e99% stenoses, having now stratified for
gender. As can be seen, males appear to gain continu-
ing benefit from CEA (albeit cumulatively reduced
with time) for both moderate (50e69%) and severe
(70e99%) stenosis subgroups.4 Contrast this with
what appears to be happening in females. Notwith-
standing methodological criticisms regarding the
validity of subgroup analyses and whether the trials
were adequately powered, the CETC data suggestEur J Vasc Endovasc Surg Vol 35, April 2008
388 A. R. Naylora very clear trend towards little benefit accruing to the
female patient if surgery is deferred beyond four
weeks, even if severe carotid disease was present.
This author does not suggest that we should now
stop operating on all symptomatic female patients
should 4þ weeks elapse, but can anyone really look
at the data in Table 4 and Fig. 2 and still say that
‘delay to surgery’ does not matter?
Something Blue.
The rationale underlying early surgery in patients
presenting with TIA and minor stroke includes;
improving overall cerebral perfusion, reducing cumu-
lative neuronal loss by restoring blood flow to the
ischaemic penumbra, preventing early progression
towards thrombosis and, of course, removing a source
of ongoing embolism.
But doesn’t early surgery increase the procedural
risk and so negate any long term benefit to the patient?
This is another very important and often confounding
issue. There have been a number of publications citing
30-day outcomes in patients undergoing early/urgent
carotid surgery, but very few centres have published
median delay data for all of their symptomatic pa-
tients. In a recent review of the available literature,4
only Vancouver has published a median delay of
14 days from onset of symptoms to surgery for all
patients.35 Interpretation: surgeons are aware of the
AAN and AHA ‘two week’ recommendations, but
most will say that they do not have the infra-structure
to achieve it.
Or is there, perhaps, another important factor to be
considered in this debate? I suspect that while most
surgeons do accept that rapid intervention will cap-
ture some of the patients who would previously
have suffered a stroke before any intervention could
be offered, they remain concerned that any increased
procedural risks incurred by implementing such
a strategy might lead to unwarranted professional
censure and criticism. After all, who wants to be pub-
licly labelled as one of the worst performing carotid
surgeons if a little bit of delay in the system conve-
niently avoided this? Anyone who doubts the
ability/intention of the media to criticise individual
surgeon’s performances might like to read the July
12th edition of the San Diego Union Tribune36 which
lists the ‘best’ and ‘worst’ performing cardiac sur-
geons in the state of California. League tables are
fine provided they stratify for case-mix. To-date, no
national guideline has ever considered ‘very early
surgery’ within its ‘accepted’ risk recommendations.
The paradox of early intervention equating to in-
creased risk was amply highlighted by a veryEur J Vasc Endovasc Surg Vol 35, April 2008important paper from New York which showed that
symptomatic patients undergoing CEA within 4
weeks of the index event incurred a threefold increase
in the 30-day death/stroke risk from 1.6% to 5.1%.9
The authors concluded (in their manuscript title)
that ‘‘early endarterectomy was associated with
poorer peri-operative outcomes’’, thereafter recom-
mending that it might be better to delay surgery in
order to get better procedural results. Given the style
of reporting in the San Diego Union Tribune, it might
be hard not to agree with them!
So how can this paradox be reconciled, especially
as the first half of this paper has provided compelling
evidence that the highest risk period for a patient
suffering a TIA or minor stroke is the first seven
days? Two further sets of evidence and an alternative
way of interpreting the literature may provide a solu-
tion, provided future ‘Guideline Makers’ recognise that
a slight increase in the accepted early procedural risk
is acceptable in selected patients.
Is Rockman’s experience of increased procedural
risk consistent with other published studies? Bond
et al.37 performed a systematic review of the published
data (11 trials, 4278 patients) and compared the 30-day
risk of stroke/death in patients presenting with a mi-
nor stroke who underwent either early CEA (<3 to 6
weeks) versus late CEA (>3 to 6 weeks). The findings
were consistent across all of the studies in the review
and no excess risk was associated with early versus
late CEA, provided the patient presented with stable
neurological symptoms (Pooled Odds Ratio¼ 1.13,
95% CI 0.79e1.62). This suggests that surgery within
the previously accepted 6 week threshold was not
associated with excess risk.
Few studies have, however, published outcomes
when CEA was performed within the ‘two week’
recommendation laid down by the AAN and the
AHA. Table 5 details 30-day outcomes and conversion
rates to intracranial haemorrhage in 8 studies pub-
lished since 2000 where the median delay from onset
of events to surgery was <14 days.38e45 In seven stud-
ies, the median delay to surgery was <7 days. There
was no standardisation within studies regarding
scoring the severity of a ‘stroke’ and only four studies
documented that there was independent neurological
assessment.
The first key message from reviewing these studies
was that the overall 30-day death/stroke rates proba-
bly were higher than that cited in the ‘popular’ litera-
ture. However, the highest 30-day risk (16.4%) was
probably not typical of the type of patient normally
being considered for early intervention. Huber’s
study included patients with a high proportion of
residual severe neurological deficits (48%) and some
Table 5. 30-Day Death/Stroke rates following CEA when performed within a median of 14 days since onset of symptoms
Reference Year n Symptom Median days
from event to CEA
Stroke score 30-day death/stroke ICHa
Ricco38 2000 72 CVA 5.5 (range 2e15) NESS¼3e 2.8% 0.0%h
Paty39 2004 72 CVA <7 ‘non-disabling’ 2.8% not stated
Paty39 2004 131 CVA <14 ‘non-disabling’ 3.1% not stated
Dorigo40 2007 70 CVA/TIA 2.0 ‘non-disabling’ 5.4%g not stated
Aleksic41 2006 50 CVA/TIA 4.5 (range 1e21) Rankin <4 6.0% 4.0%i
Karkos42 2007 42 TIAc 3.0 (range 1e7) Rankin <4 7.0% 0.0%h
Sbarigia43 2006 96 CVA 1.5 (range 1e11) NIHSS <22f 7.3%g 0.0%h
Rantner44 2006 226b CVA 12 (IQR 8e19) 66% Rankin 2 8.4%g 0.4%h
Huber45 2003 67 CVA/TIAd 2.0 (range 0e18) 48% Rankin 3e5 16.4%g 1.5%h
a prevalence of intracranial haemorrhage.
b Rantner’s paper combined data from Eckstein17, Woelfle46 and Rantner.47
c cohort had suffered 3 TIAs in preceding 7 days.
d mixed cohort including completed strokes, crescendo TIAs and patients with carotid occlusion and severe (Rankin 3e5) neurological
deficits.
e Neurological Event Severity Score.
f NIHSS¼National Institute of Health Stroke Scale.
g independent neurological verification of outcomes.
h post-op CT scans only done in patients with worsening/new neurological deficit. None of these had CT evidence of new haemorrhage.
i new haemorrhage present on CT scan, but not associated with symptoms.
150
200
250
300
<2 wks 2-4 wks 4-12 wks >12 wks
389Delay Comes With a Pricewith carotid occlusion.45 The second key message was
that the rate of conversion to intracranial haemorrhage
was reassuringly low, although there was no real con-
sistency regarding the performance of routine post-op-
erative CT scans unless there were complications.
Rantner’s study44 (226 stroke patients) combined
patients from three contributory databases17,46,47 and
represents the largest published series to-date. Two
thirds of Rantner’s stroke patients were classified as
‘minor’ on the modified Rankin system (0e2) and
the 30-day death/stroke rate of 8.4% probably repre-
sents ‘real world’ practice, especially as it included
independent neurologist assessment.
Many of the constituent studies listed in Table 5
were too small to provide reliable guidance regarding
which patients with stroke benefited most (and least)
from early intervention, but a number of common
themes emerged. The literature suggests that patient
subgroups in whom one should ‘avoid’ early surgery
include; (i) evidence of recent carotid occlusion,41 (ii)
Rankin score 341,44 (Table 6), (iii) ischaemic infarct
>two thirds of the middle cerebral artery territory43
(iv) no neurological plateau44 (v) fluctuating con-
scious levels and (vi) evidence of intracranialTable 6. The modified Rankin scoring system48
0 no deficit
1 minimal deficit without any functional impairment
2 minor deficit, slight functional impairment, patient
independent
3 moderate deficit, patient can walk alone, needs some
assistance in daily life
4 severe deficit, patient can walk only with assistance
5 disabling stroke, patient confined to bed or wheelchair
6 deadhaemorrhage on CT scan. The worst outcomes after
early CEA (23% death/stroke rate at 30-days) were
seen in stroke patients presenting with the combina-
tion of a Rankin score 3þ an ASA score >2þCEA
within 12 days.44 This excessively high procedural
risk compares with a 30-day death/stroke rate of
6.4% in patients presenting without this combination.
If one accepts that Rantner’s data from a large co-
hort of independently monitored patients undergoing
surgery within 14 days of a stroke reflects ‘real world’
practice, is there any evidence to suggest that their
8.4% procedural risk represents poor surgical prac-
tice? I suspect that many surgeons will, intuitively,
say yes. However, the data from Fig. 3 might convince
them otherwise! Fig. 3 presents an alternative way of
interpreting the CETC database. Because the CETC
provided the ‘raw’ 5 year medical and surgical stroke
risks as well as the procedural risks stratified for the-50
0
50
100
0 1 2 3 4 5 6 7 8 9 10
30-day death/stroke rate (%)
Fig. 3. Strokes prevented per 1000 CEAs at 5 years stratified
for; (i) delay from last event to surgery and (ii) 30-day death/
stroke risk (recalculated from CETC10e12 and reproduced with
permission from AR Naylor).4
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benefit conferred by CEA depending on different de-
lays to surgery and procedural risks.4 For example,
a surgeon operating within 2 weeks of the index event
with a 10% procedural risk (which most of you I suspect
will think unacceptable) will still prevent 150 strokes at
5 years per 1000 CEAs performed. Despite the very high
initial risk used in this example, the CETC data suggest
that this surgeon will still prevent more strokes in the
long term than if he/she waited for >4 weeks and
then operated with zero risk! Bear that in mind the
next time you are asked to interpret published
outcomes in the literature or are tempted to criticise
surgeons/interventionists who operate very early!In Conclusion
To this observer, the natural history data document-
ing the high early risk of stroke after suffering
a TIA/minor stroke are quite compelling. The system
currently ignores the very highest risk patients and
commits far too many resources towards treating rel-
atively low risk patients. The ‘48 hour’ aspirations of
the UK Government are almost certainly beyond the
reach of most centres, but a seven day target to treat-
ment would be an absolutely massive improvement
in practice and will prevent far more strokes in the
long term than by treating large numbers of asymp-
tomatic individuals. However, ‘Guideline Makers’
must recognise that a drive towards rapid interven-
tion will probably come at the expense of a slightly
increased procedural risk. Unless this is recognised,
few surgeons will change their practice for fear of
being labelled as ‘poorly performing’. As a (personal)
suggestion, what about considering that a 30-day
death/stroke risk of 8% is acceptable if CEA is per-
formed within 2 weeks of the index event, reducing
this threshold of acceptable risk to 6% if surgery is
performed between 2e4 weeks and down to 4% if
CEA is delayed beyond 4 weeks. If you are still
moved to disagree with this suggestion, look again
at Fig. 3 and see for your self which threshold is pre-
venting the most strokes in the long term!Conflict of interest
None.
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